Caribou Biosciences (CRBU)’s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street
On February 2, 2026, Clear Street began covering Caribou Biosciences, Inc. (NASDAQ:CRBU) with a ‘Buy’ rating and a $13 price target.
Caribou Biosciences Inc. (CRBU)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kynam Capital Derrick Tang | 2,503,302 | $3,980,250 | -19% | 0.25% |
| 2. | Renaissance Technologies Jim Simons | 1,639,857 | $2,607,373 | +111% | 0% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 1,115,700 | $1,773,963 | -10% | 0% |
| 4. | Partner Fund Management Christopher Medlock James | 957,787 | $1,522,881 | -30% | 0.15% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 881,105 | $1,400,957 | +601% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.02 | 20,000 | $20,400.00 | 3,369,395 | 2025-03-14 | Filing | |
| $1.42 | 17,360 | $24,651.20 | 17,360 | 2025-01-29 | Filing | |
| $4.11 | 6,818 | $28,021.98 | 109,082 | 2022-01-11 | Filing | |
| $2.69 | 569 | $1,530.61 | 102,264 | 2022-01-11 | Filing | |
| $2.69 | 1,136 | $3,055.84 | 101,695 | 2021-12-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.96 | 3,147 | $6,168.12 | 79,353 | 2026-02-24 | Filing | |
| $1.96 | 6,938 | $13,598.48 | 481,564 | 2026-02-24 | Filing | |
| $1.96 | 6,938 | $13,598.48 | 104,998 | 2026-02-24 | Filing | |
| $1.96 | 1,066 | $2,089.36 | 68,523 | 2026-02-24 | Filing | |
| $1.35 | 3,564 | $4,811.40 | 443,502 | 2025-02-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,690,431 | $7,457,785 | 3.15% | |
| 2. | 4,304,198 | $6,843,676 | 0% | |
| 3. | 2,141,023 | $3,404,227 | 0% | |
| 4. | 1,388,905 | $2,208,359 | 0% | |
| 5. | 1,031,375 | $1,639,887 | 0% |
News See All
7 Most Volatile Stocks Under $5 for Day Trading
Morningstar released its Q1 2026 U.S. Stock Market Outlook report last month. Led by Chief U.S. Economist Preston Caldwell and Chief U.S.
Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
5 $10 Stocks That Will Triple
Borr Drilling Limited (NYSE:BORR) is a global offshore drilling contractor for the oil and gas industry.
These 5 Stocks Under $10 Are Poised To Explode
Spire Global, Inc. (NYSE:SPIR) is one of the cheap stocks under $10 for anyone eyeing exposure in the industrial sector. Spire Global, Inc.
12 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 12 gene editing stocks with the best long-term potential.
10 Best Gene Editing Stocks To Buy
A report by The Wall Street Journal dated September 16 suggests that Intellia Therapeutics, Inc.
9 Healthcare Stocks to Invest In Today According to Stanley Druckenmiller
In this piece, we will take a look at the nine healthcare stocks to invest in today according to Stanley Druckenmiller.
5 Biotech Stocks to Sell Now According to Cathie Wood
In this article, we discuss 5 biotech stocks to sell now according to Cathie Wood.
Hedge Fund Resource Center